Featured
What is already known about this
topic?
Face masks or respirators
(N95/KN95s) effectively filter virus-sized particles in laboratory settings.
The real-world effectiveness of face coverings to prevent acquisition of
SARS-CoV-2 infection has not been widely studied.
What is added by this report?
Consistent use of a face mask or
res...
Clinical Infectious Diseases: By
Infectious Diseases Society of America
TAKE-HOME MESSAGE
This study addressed the predictors
of SARS-CoV-2 infection among participants who reported social contact with an
individual known or suspected of having SARS-CoV-2 infection. Among
unvaccinated and partially vaccinated participants, factors suc...
JAMA Internal Medicine:
Key Points
Question What
is the risk of perinatal complications associated with SARS-CoV-2 infection
during pregnancy and what factors are associated with hospitalizations?
Findings In
this cohort study of 43 886 pregnant individuals, SARS-CoV-2 infection during
pregnancy was associated with an increased ris...
BMJ: British Medical Journal
This
retrospective case series analysis compared the incidence of immune-mediated
neurologic events among over 8 million individuals vaccinated against COVID-19,
over 700,000 unvaccinated individuals diagnosed with COVID-19, and a historical
cohort of over 14 million individuals in the general population....
European Journal of Neurology:
Neurological complications
associated with acute coronavirus disease 2019 (COVID-19) are well described.
Now, increasing evidence suggests that symptoms may persist even beyond
4–12 weeks after disease onset
Frequent neurological, cognitive
and neuropsychiatric long-term symptoms after COVID-19 include b...
American Journal of Obstetrics and Gynecology:
Key findings
Vaccine-generated antibodies were
present in umbilical cord blood and breastmilk after maternal vaccination.
Pregnant and lactating women
elicited comparable vaccine-induced humoral immune responses with nonpregnant
controls and generated higher antibody titers than those o...
JAMA Network:
SARS-CoV-2 continues to infect more
than 22 million patients per week and globally causes more than 65 000 deaths
per week as of January 31, 2022.
Although aspirin has not been shown
to reduce major adverse cardiovascular or pulmonary events in symptomatic
outpatients with COVID-19, several observational studies have fou...
American College of Physicians (ACP) Journals: Annals of Internal
Medicine
Nirmatrelvir–ritonavir (NMV/r) is use in high-risk patients with
mild to moderate COVID-19 who are likely to be receiving other medications. NMV/r
administered within three days of symptom onset reduced the risk of COVID-19
related hospitalization and death from a...
European Heart Journal:
Emerging as a new epidemic, long COVID or post-acute sequelae
of coronavirus disease 2019 (COVID-19), a condition characterized by the
persistence of COVID-19 symptoms beyond 3 months. The long-term impact of COVID-19 on cardiovascular (CV) health and
mortality is also emerging as a major global concern.
Definit...
The human
pancreas is a target of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). New-onset hyperglycaemia and insulin resistance have been
reported in patients with coronavirus disease-2019 (Covid-19) without history
of diabetes.
However,
it is unclear whether such metabolic alterations are transient or whether
individu...
The
FDA has authorized use of the nirmatrelvir/ritonavir, for the treatment of mild
to moderate COVID-19. Studies have indicated that it is 88% effective at
preventing hospitalization and death from COVID-19.
Criteria
for Prescribing
To prescribe nirmatrelvir/ritonavir,
prescribers should confirm that the following criteria have been...
Urinary
tract infections (UTIs) represent a common pathology among female patients,
leading to overprescribing antibiotics, globally. The emergence of the COVID-19
pandemic has dramatically increased the incidence of this particular viral
pneumonia with secondary bacterial superinfection, resulting in continuous
therapeutic or prophylactic...
